Method development, right first time
Modern pharmaceutical business drivers are continually pushing to reduce the time it takes to get a product or service to market, reduce the risk and cost associated with that and to improve quality. In laboratories, delivering an analytical result that's right the first time is the answer.
Built with the rigours of pharmaceutical development in mind, our Chromatography Data System (CDS) and informatics solutions have capabilities targeted at various drug development applications, including: method development, method optimization, ICH method validation tools, dissolution testing, content uniformity testing, 21CFR11 compliance, and gel permeation chromatography.
Tenofovir belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (NRTIs), which block reverse transcriptase, an enzyme crucial to viral production.
UHPLC Method Development for Analyzing a Once-Daily Tablet Formulation for HIV-1 Infection Treatment
The HIV-1 specific medication has progressed from monotherapy in the early 1990s towards combination therapies of different antiretroviral agents (ARVs), resulting in numerous pills that a patient must consume.
Industry expert and acclaimed scientist Dr. Tony Edge presents together with HPLC expert Dr. Frank Steiner on this informative webinar that discusses novel column techniques and detection technologies to improve pharmaceutical discovery.